First new oral medication to treat Deep Vein Thrombosis in 60 years approved by FDA
The Food and Drug Adminstration has announced approval of Rivaroxaban (Xarelto), the first oral medication approved for the treatment of DVT since the approval of Warfarin (Coumadin) 60 years ago. Rivaroxaban’s approval was based mainly on results from three trials […]
First new oral medication to treat Deep Vein Thrombosis in 60 years approved by FDA Read More »